SPY369.85+3.16 0.86%
DIA302.59+2.53 0.84%
IXIC12,464.23+87.05 0.70%

Surgalign Holdings And Aziyo Biologics Announce Expanded Distribution Agreement

Updated agreement expands availability of ViBone® Moldable, a next generation moldable cellular bone matrix product DEERFIELD, Ill. and SILVER SPRING, Md., Nov. 16, 2020 (GLOBE NEWSWIRE) -- Surgalign Holdings, Inc.

· 11/16/2020 16:08

Updated agreement expands availability of ViBone® Moldable, a next generation moldable cellular bone matrix product

DEERFIELD, Ill. and SILVER SPRING, Md., Nov. 16, 2020 (GLOBE NEWSWIRE) -- Surgalign Holdings, Inc. (NASDAQ:SRGA), a global pure-play spine company focused on advancing spine surgery including through the application of digital technologies to improve patient outcomes, and Aziyo Biologics, Inc. (NASDAQ:AZYO), a commercial-stage regenerative medicine company, today announced an updated distribution agreement and expanded product offering whereby Aziyo will provide ViBone® Moldable to Surgalign for distribution in the U.S. ViBone Moldable joins Surgalign’s orthobiologic solutions to support spinal fusion, which currently include ViBone and other advanced bone graft solutions.